申舒斯醫療保健 SRTS 深 滬
已收盤 04-02 16:00:00 美东时间
4.11
-0.090
-2.14%
華盛通- 最 高4.22
- 今 開4.13
- 成交量 1.50万股
- 最 低 3.86
- 昨 收 4.20
- 總市值 6765.91万
- 52周最高 5.92
- 市盈率 靜 --
- 換手率 0.09%
- 52周最低 3.03
- 委 比 -36.85%
- 總股本 1646.21万
- 歷史最高 15.25
- 量 比 0.30
- 振 幅 8.57%
- 歷史最低 1.76
- 每 手 1
- 風險率 0.67%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sensus Healthcare Sues SkinCure Oncology Over Alleged Violation Of Contract Related To Unpaid Amounts Owed For Sensus Products
Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today
03-27 20:10
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Jasper Therapeutics (NASDAQ:JSPR) stock rose 19.6% to $1.4 during Frid...
02-13 20:05
Sensus Healthcare shares are trading lower after the company reported worse-than-expected Q4 financial results.
Sensus Healthcare shares are trading lower after the company reported worse-tha...
02-13 05:42
Earnings Scheduled For February 12, 2026
Companies Reporting Before The Bell • Ambev (NYSE:ABEV) is estimated to report ...
02-12 19:11
Sensus Healthcare Appoints Eric Sachetta as Director
Sensus Healthcare ( ($SRTS) ) has shared an announcement. On November 10, 2025,...
2025-11-13 23:27
电话会总结 ｜ Sensus SRTS Q3 2025 业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Sensus Healthcare (SRTS) Q3 2025业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **Q3 2025财务表现：** - 营收：690万美元，同比下降21.6%（Q3 2024为880万美元） - 毛利润：270万美元，同比下降48.1%（Q3 2024为520万美元） - 毛利率：39.1%，同比大幅下降20个百分点（Q3 2024为59.1%） - 净亏损：90万美元（每股亏损6美分），而Q3 2024为净利润120万美元（每股收益7美分） - 调整后EBITDA：负240万美元，而Q3 2024为正1
2025-11-07 12:07
Sensus Healthcare Faces Mixed Earnings Amid Challenges
Sensus Healthcare, Inc. (($SRTS)) has held its Q2 earnings call. Read on for th...
2025-08-13 09:18
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
2025-08-11 09:43
Sensus Healthcare Q2 EPS $(0.06) Misses $0.03 Estimate, Sales $7.315M Miss $9.301M Estimate
Sensus Healthcare (NASDAQ:SRTS) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $0.03 by 330.77 percent. This is a 160 percent decrease over earnings of $0.10 per share from
2025-08-08 04:18
美股大行评级 | 潜在涨幅300.0%！HC Wainwright & Co.：Armata Pharmaceuticals获机构升目标价至9美元，维持"买入"评级
潜在涨幅300.0%！HC Wainwright & Co.：Armata Pharmaceuticals获机构升目标价至9美元，维持"买入"评级
2025-05-21 16:44
